Abstract
Purpose
Cases of fracture-fixation device infection involving Staphylococcus lugdunensis are not frequent. The clinical characteristics and the choice of treatment strategies of these infections are not obviously known to date.
Methods
We performed a review of fracture-fixation device infection involving S. lugdunensis managed by our centres.
Results
Among the 38 cases of fracture-fixation device infection involving S. lugdunensis, 53% were located in the tibia. Most of our cases (87%) were chronic infections. Purulent discharge, which occurred in 79% of cases, was the most frequent clinical symptom, followed by pain in 63%, local inflammation in 55%, and fever in 37%. Bacteremia and severe sepsis occurred in 10% and 18% of cases, respectively. Four cases (10%) were treated exclusively with antimicrobial treatment alone. Thirty-four cases (89%) were treated with a combination of surgery with antimicrobial therapy including surgical debridement, antibiotics and osteosynthesis device retention in six cases (16%), and osteosynthesis device removal in 27 cases (71%). The mean length of antibiotic treatment was 119 days. The relapse rate was high that was not related to selection of resistant strains. Polymicrobial infection had no impact on clinical outcome. A combination of surgery with antimicrobial therapy was identified as a significant prognostic factor associated with remission (p = 0.042).
Conclusions
S. lugdunensis is probably involved in more infections than has been reported. Using appropriate microbiological methods laboratories should routinely identify the species of all coagulase-negative Staphylococci isolates involved in fracture-fixation device infection to better achieve the treatment strategies of fracture-fixation device infection involving S. lugdunensis.
Similar content being viewed by others
References
Freney J, Brun Y, Bes M et al (1988) Staphylococcus lugdunensis sp. nov. and staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Evol Microbiol 38:168–172. doi:10.1099/00207713-38-2-168
Ravaioli S, Selan L, Visai L et al (2012) Staphylococcus lugdunensis, an aggressive coagulase-negative pathogen not to be underestimated. Int J Artif Organs 35:742–753. doi:10.5301/ijao.5000142
Frank KL, Del Pozo JL, Patel R (2008) From clinical microbiology to infection pathogenesis: how daring to be different works for staphylococcus lugdunensis. Clin Microbiol Rev 21:111–133. doi:10.1128/CMR.00036-07
Hussain M, Steinbacher T, Peters G et al (2015) The adhesive properties of the staphylococcus lugdunensis multifunctional autolysin AtlL and its role in biofilm formation and internalization. Int J Med Microbiol IJMM 305:129–139. doi:10.1016/j.ijmm.2014.11.010
Lourtet-Hascoët J, Bicart-See A, Félicé MP et al (2016) Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis. Int J Infect Dis 51:56–61. doi:10.1016/j.ijid.2016.08.007
Shah NB, Osmon DR, Fadel H et al (2010) Laboratory and clinical characteristics of staphylococcus lugdunensis prosthetic joint infections. J Clin Microbiol 48:1600–1603. doi:10.1128/JCM.01769-09
Sanzéni L, Ringberg H (2003) Fistulating periprosthetic staphylococcus lugdunensis hip infection cured by intra-articular teicoplanin injections—a case report. Acta Orthop Scand 74:624–625. doi:10.1080/00016470310018072
Szabados F, Anders A, Kaase M et al (2011) Late Periprosthetic joint infection due to staphylococcus lugdunensis identified by matrix-assisted laser desorption/ionisation time of flight mass spectrometry: a case report and review of the literature. Case Rep Med 2011:608919. doi:10.1155/2011/608919
Guttmann G, Garazi S, Van Linthoudt D (2000) Spondylodiscitis due to staphylococcus lugdunensis. Clin Exp Rheumatol 18:271–272
Fleurette J, Bès M, Brun Y et al (1989) Clinical isolates of staphylococcus lugdunensis and S. Schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol 140:107–118
Greig JM, Wood MJ (2003) Staphylococcus lugdunensis vertebral osteomyelitis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 9:1139–1141
Thomas S, Hoy C, Capper R (2006) Osteomyelitis of the ear canal caused by staphylococcus lugdunensis. J Inf Secur 53:e227–e229. doi:10.1016/j.jinf.2006.02.005
Kragsbjerg P, Bomfim-Loogna J, Törnqvist E, Söderquist B (2000) Development of antimicrobial resistance in staphylococcus lugdunensis during treatment-report of a case of bacterial arthritis, vertebral osteomyelitis and infective endocarditis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 6:496–499
Sampathkumar P, Osmon DR, Cockerill FR 3rd (2000) Prosthetic joint infection due to staphylococcus lugdunensis. Mayo Clin Proc 75:511–512. doi:10.4065/75.5.511
Huang HL, Soo Rui Ting M, Olszyna DP et al (2016) Localization of staphylococcus Lugdunensis Clavicular osteomyelitis using FDG-PET/CT. Am J Med 129:e9–e11. doi:10.1016/j.amjmed.2015.10.040
Seng P, Traore M, Lagier J-C et al (2017) Staphylococcus lugdunensis: an underreported pathogen in osteomyelitis. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg. doi:10.1053/j.jfas.2016.10.018
Trampuz A, Zimmerli W (2006) Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 37(Suppl 2):S59–S66. doi:10.1016/j.injury.2006.04.010
Zimmerli W (2014) Clinical presentation and treatment of orthopaedic implant-associated infection. J Intern Med 276:111–119. doi:10.1111/joim.12233
Seng P, Barbe M, Pinelli PO et al (2014) Staphylococcus Caprae bone and joint infections: a re-emerging infection? Clin Microbiol Infect 20:O1052–O1058. doi:10.1111/1469-0691.12743
Roffman CE, Buchanan J, Allison GT (2016) Charlson comorbidities index. J Physiother 62:171. doi:10.1016/j.jphys.2016.05.008
Kear S, Smith C, Mirmiran R, Hofinger D (2016) Staphylococcus lugdunensis: a rare pathogen for osteomyelitis of the foot. J Foot Ankle Surg Off Publ Am Coll Foot Ankle Surg 55:255–259. doi:10.1053/j.jfas.2014.06.019
Karnani R, Myers JP (2008) Bone and joint infections caused by staphylococcus lugdunensis: report of 2 cases and review of the literature. Infect Dis Clin Pract 16:94–99
Douiri N, Lefebvre N, Riegel P et al (2016) Staphylococcus lugdunensis: a virulent pathogen causing bone and joint infections. Clin Microbiol Infect. doi:10.1016/j.cmi.2016.05.031
Johnson LB, Burket JS, Kauffman CA (1999) Staphylococcus lugdunensis infection following spinal fusion. Infect Dis Clin Pract 8:206–208
Szabados F, Nowotny Y, Marlinghaus L et al (2011) Occurrence of genes of putative fibrinogen binding proteins and hemolysins, as well as of their phenotypic correlates in isolates of S. Lugdunensis of different origins. BMC Res Notes 4:113. doi:10.1186/1756-0500-4-113
van der Mee-Marquet N, Achard A, Mereghetti L et al (2003) Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J Clin Microbiol 41:1404–1409
McHardy IH, Veltman J, Hindler J et al (2017) Clinical and microbiological aspects of β-lactam resistance in staphylococcus lugdunensis. J Clin Microbiol 55:585–595. doi:10.1128/JCM.02092-16
Acknowledgements
The authors would like to thank Catherine Peruffo for their helpfulness in this study.
Author information
Authors and Affiliations
Contributions
Piseth Seng: 1st author, he was involved clinical data collection, conception, design and drafting the manuscript.
Madou Traore: 2nd author, clinical data collection, microbiological data collection, manuscript revision.
Jean-Philippe Lavigne: 3rd author, microbiological data verification, manuscript revision.
Laurence Maulin: 4th author; clinical data verification, manuscript revision.
Jean-Christophe Lagier: 5th author, clinical data verification, manuscript revision.
Jean-François Thiery: 6th author, surgical data verification, manuscript revision.Jean-François Thiery: 6th author, surgical data verification, manuscript revision.
Pierre-Yves Levy: 7th author, microbial data verification, manuscript revision.
Pierre-Marie Roger: 8th author , clinical data verification, manuscript revision.
Eric Bonnet: 9th author , clinical data verification, manuscript revision.
Albert Sotto: 10th author , clinical data verification, manuscript revision.
Andreas Stein: final author, clinical data verification, discussion section, final approval of the version to be published.
All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
There is no funding source.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study. This study was approved by the institutional research ethics board (Comité de Protection des Personnes Sud Méditerranée 1). Copies of the written approval are available for review by the Editor-in-Chief of this journal.
Electronic supplementary material
Supplementary Fig. 1
(PPTX 96 kb).
Table S1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Seng, P., Traore, M., Lavigne, JP. et al. Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices. International Orthopaedics (SICOT) 41, 1085–1091 (2017). https://doi.org/10.1007/s00264-017-3476-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-017-3476-4